Signal active
Organization
Contact Information
Overview
VIRxSYS Corporation is a privately-held biotechnology company with proprietary platform technologies with which the Company intends to develop therapies for serious human diseases.
About
Biotechnology, Health Care, Medical, Genetics
1998
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VIRxSYS headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Genetics sector. The company focuses on Biotechnology and has secured $11.5B in funding across 112 round(s). With a team of 11-50 employees, VIRxSYS is actively contributing to advancements in Biotechnology. Their latest funding round, Series G - VIRxSYS, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
7
0
0
$102.9M
Details
5
VIRxSYS has raised a total of $102.9M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2003 | Late Stage Venture | 2.8M | ||
2002 | Late Stage Venture | 5.3M | ||
2005 | Late Stage Venture | 30.0M | ||
2006 | Late Stage Venture | 20.0M |
Investors
VIRxSYS is funded by 2 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
VIRxSYS | - | FUNDING ROUND - VIRxSYS | 5.3M |
Boro Dropulic | - | FUNDING ROUND - Boro Dropulic | 5.3M |
Recent Activity
There is no recent news or activity for this profile.